Evidence map›Paper›PMID 25756522›Full record

Observational studyPloS one2015

Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan.

Li-Ting Ho, Wei-Hsian Yin, Shao-Yuan Chuang, Wei-Kung Tseng, Yen-Wen Wu, I-Chang Hsieh, Tsung-Hsien Lin, Yi-Heng Li, Lien-Chi Huang, Kuo-Yang Wang and 7 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Review
  12. Outcomes of Secondary Prevention among Coronary Heart Disease Patients in a High-Risk Region in Finland.International journal of environmental research and public health · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 14 institutions in 1 country.

Li-Ting HoDivision of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan.
Wei-Hsian YinDivision of Cardiology, Heart Center, Cheng-Hsin General Hospital, and School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Shao-Yuan ChuangInstitute of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan.
Wei-Kung TsengDepartment of Medical Imaging and Radiological Sciences, I-Shou University and Division of Cardiology, Department of Internal Medicine, E-Da Hospital, Kaohsiung, Taiwan.
Yen-Wen WuCardiology Division of Cardiovascular Medical Center and Department of Nuclear Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
I-Chang HsiehSecond Department of Cardiology, Chang-Gung Memorial Hospital, New Taipei City, Taiwan.
Tsung-Hsien LinDivision of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital and Kaohsiung Medical University, Kaohsiung, Taiwan.
Yi-Heng LiDepartment of Internal Medicine, National Cheng Kung University Hospital and College of Medicine, Tainan, Taiwan.
Lien-Chi HuangDepartment of Cardiology, Taipei Union Hospital, Taipei, Taiwan.
Kuo-Yang WangCardiovascular Center, Taichung Veterans General Hospital and Department of Medicine, Chung-Shan Medical University, Taichung, Taiwan.
Kwo-Chang UengSchool of Medicine, Chung Shan Medical University and Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
Ching-Chang FangDivision of Cardiology, Department of Internal Medicine, Tainan Municipal Hospital, Tainan, Taiwan.
Wen-Harn PanInstitute of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan.
Hung-I YehMackay Memorial Hospital, Mackay Medical College, New Taipei City, Taiwan.
Chau-Chung WuDivision of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan; Department of Primary Care Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Jaw-Wen ChenDepartment of Medical Research and Education, Taipei Veterans General Hospital and Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan.
Taiwanese Secondary Prevention for patients with AtheRosCLErotic disease (T-SPARCLE) Registry Investigators
National Health Research Institutes · TWNational Taiwan University Hospital · TWChang Gung Memorial Hospital · TWChung Shan Medical University · TWChung Shan Medical University Hospital · TWE-Da Hospital · TWFar Eastern Memorial Hospital · TWKaohsiung Medical University · TWMackay Memorial Hospital · TWNational Cheng Kung University Hospital · TWNational Yang Ming Chiao Tung University · TWTainan Municipal Hospital · TWTaipei Hospital · TWTaipei Veterans General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEpidemiological and clinical studies have clearly established the link between low-density lipoprotein cholesterol (LDL-C) and atherosclerosis-related cardiovascular consequences. Although it has been a common practice for physicians to prescribe lipid-lowering therapy for patients with dyslipidemia, the achievement rate is still not satisfied in Taiwan. Therefore, the determinants for achieving the LDL-C target needed to be clarified for better healthcare of the patients with dyslipidemia.

methodThis registry-type prospective observational study enrolled the patients with cardiovascular diseases (coronary artery disease (CAD) and cerebrovascular disease (CVD)) from 18 medical centers across Taiwan, and clinically followed them for five years. At every clinical visit, vital signs, clinical endpoints, adverse events, concurrent medications and laboratory specimens were obtained as thoroughly as possible. The lipid profile (total cholesterol, high-density lipoprotein cholesterol, LDL-C, triglyceride), liver enzymes, and creatinine phosphokinase were evaluated at baseline, and every year thereafter. The cross sectional observational data was analyzed for this report.

resultAmong the 3,486 registered patients, 54% had their LDL-C < 100 mg/dL. By univariate analysis, the patients achieving the LDL-C target were associated with older age, more male sex, taller height, lower blood pressure, more under lipid-lowering therapy, more smoking cessation, more history of CAD, DM, physical activity, but less history of CVD. The multivariate analysis showed statin therapy was the most significant independent determinant for achieving the treatment target, followed by age, history of CAD, diabetes, blood pressure, and sex. However, most patients were on regimens of very-low to low equipotent doses of statins.

conclusionAlthough the lipid treatment guideline adherence is improving in recent years, only 54% of the patients with cardiovascular diseases have achieved their LDL-C target in Taiwan, and the most significant determinant for this was statin therapy.

Indexed as

AgedCholesterol, LDLCoronary Artery DiseaseCross-Sectional StudiesFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypercholesterolemiaMaleMiddle AgedProspective StudiesSecondary PreventionTaiwanTreatment OutcomeCholesterol, LDLHydroxymethylglutaryl-CoA Reductase Inhibitors

Identifiers

PMID25756522
PMCPMC4355583
OpenAlexW2052470716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.